Back to the main directory
EarningsReview / Equity
- Waiting for the Halo by BNP Paribas Exane
- Reversal of Reserves Researched by BNP Paribas Exane
- Hone in on HALEU Remarks by BNP Paribas Exane
- Itaú BBA on SMU: Expense Pressures Persist, Gross Margins Hold , Sales Momentum Remains Elusive by Itau
- Itaú BBA on Quero-Quero: 2Q25: Macro Still The Hardest Competitor by Itau
- Itaú BBA on Even: Soft 2Q25 Earnings Result by Itau
- Is the tide turning in Turkish equities? by BNP Paribas Exane
- Will US BESS ‘Spark’ Light All Circuits? Still Unproven. by BNP Paribas Exane
- View from the Bluegrass State by BNP Paribas Exane
- Carl Zeiss Meditec - CHINESE SYNDROME by Equita Sim
- Unipol - SOLID FUNDAMENTALS POINT TO VALUATION CATCH-UP by Equita Sim
- B3 (B3SA3 BZ) by HSBC
- Unidata S.p.A - Preview Unidata 1S25 by MidCap Partners
- H125 Results: No guidance upgrade, but NTA beat by BNP Paribas Exane
- Unidata S.p.A - Preview Unidata 1H25 by MidCap Partners
- Q2’25 results: Weaker than expected by BNP Paribas Exane
- Spirax Group (+): H1’25 results: Still not firing, enough for a small bounce by BNP Paribas Exane
- First Take: In line H1 and FY guide maintained by BNP Paribas Exane
- INVEST SECURITIES - NYXOAH : Feu vert aux us ! - ACHAT, OC 11,7€ vs 10,9€ by Invest Securities
- STRATEGY, LITHIUM, B, STEEL US by BNP Paribas Exane
- H1’25: Off the call by BNP Paribas Exane
- Bonus-issue related adjustments by BNP Paribas Exane
- H1’25 Off the call: Progressing largely as planned by BNP Paribas Exane
- 2Q25 preview by BNP Paribas Exane
- Q2 conference call: How much buffer has been added to the Balance Sheet? by BNP Paribas Exane